Legend Biotech (LEGN.US) Latest Stock News - Major News Analysis - Longbridge

Quote List Quote List

Event Tracking

Dec9

RBC Maintains 'Outperform' Rating and PT on Legend Biotech

07:36

Dec8

RBC Capital analyst maintains buy rating on Legend Biotech

12:32

Dec6

Legend Biotech Announces Clinical Trial Data for CARVYKTI® and LUCAR-G39D

19:00

Dec4

Decheng Capital Reduced Legend Biotech Stock Holdings in Q2

10:21

Nov21

IvyRock Increases Stake in Legend Biotech

14:16

Nov19

Johnson & Johnson and Legend Biotech Withdraw Carvykti's Clinical Data Comparison Study with Competitors

11:37

Schedules & Filings

Schedules

Filings

Nov12

Earning Release(EST)

FY2025 Q3 Earning Release (USD) Revenue 272.33 M, Net Income -39.69 M, EPS -0.2199

Aug11

Earning Release(EST)

FY2025 Q2 Earning Release (USD) Revenue 255.06 M, Net Income -125.38 M, EPS -0.6809

May13

Earning Release(EST)

FY2025 Q1 Earning Release (USD) Revenue 195.05 M, Net Income -100.92 M, EPS -0.5491

View More

Stock List

Top Gainers

Top Decliners

China Concepts

Symbol

Price

%Chg

Change

View More